CARLOS MANUEL
PANIZO SANTOS
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (3)
2020
-
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
British Journal of Haematology, Vol. 188, Núm. 5, pp. 661-673
2010
-
Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation
Annals of Oncology, Vol. 21, Núm. 9, pp. 1891-1897
2003
-
Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized, double-blind clinical trial
Journal of Thrombosis and Haemostasis, Vol. 1, Núm. 3, pp. 425-432